Every record from PeptideMeter · page 19
Runs dual-wavelength detection as standard and reports named related substances rather than totals only. Measured offset against the reference laboratory is -0.024 pp on 569 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-018429 | NAD+ | WWB | WWB-2504-B2388 | 2025-Q2 | 99.77 | 11.26 | 90.6 | Supplier-supplied | 1 | FAIL |
| AX-2025-020717 | BPC-157 | GL Biochem | GLBI-2411-N8871 | 2025-Q2 | 98.70 | 7.66 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019679 | Retatrutide | Homopeptide | HOMO-2412-V2760 | 2025-Q2 | 98.07 | 3.85 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018953 | Tirzepatide | FGP | FGP-2412-N1589 | 2025-Q2 | 98.67 | 3.55 | 96.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020168 | NAD+ | GGPeps | GGPE-2502-W9548 | 2025-Q2 | 98.56 | 11.48 | 101.0 | Supplier-supplied | 0 | FAIL |
| AX-2025-018956 | Tirzepatide | FGP | FGP-2412-N1589 | 2025-Q2 | 98.73 | 3.96 | 93.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020297 | IGF-1 LR3 | MKM | MKM-2501-U3115 | 2025-Q2 | 97.77 | 5.50 | 106.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019885 | Retatrutide | SWB | SWB-2503-P4938 | 2025-Q2 | 98.32 | 4.50 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020222 | Tirzepatide | GGPeps | GGPE-2412-M1040 | 2025-Q2 | 98.40 | 4.33 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021140 | PT-141 (Bremelanotide) | WXT | WXT-2502-U5573 | 2025-Q2 | 98.77 | 4.51 | 96.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019324 | MK-677 (Ibutamoren mesylate) | TFC | TFC-2505-N7258 | 2025-Q2 | 99.32 | 5.58 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019768 | Semaglutide | HJ | HJ-2504-Y4203 | 2025-Q2 | 98.81 | 4.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020721 | BPC-157 | GL Biochem | GLBI-2411-N8871 | 2025-Q2 | 98.33 | 7.37 | 97.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020207 | BPC-157 | GGPeps | GGPE-2411-V1398 | 2025-Q2 | 98.73 | 2.97 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018729 | Enclomiphene citrate | QSC | QSC-2501-L7062 | 2025-Q2 | 99.26 | 6.13 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020979 | TB-500 | CPC | CPC-2502-V2965 | 2025-Q2 | 99.09 | 4.77 | 96.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019864 | Ipamorelin | SWB | SWB-2501-Y4965 | 2025-Q2 | 99.44 | 4.55 | 90.5 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-021139 | PT-141 (Bremelanotide) | WXT | WXT-2502-U5573 | 2025-Q2 | 98.45 | 4.19 | 95.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-021037 | Survodutide | WXT | WXT-2501-X3943 | 2025-Q2 | 97.37 | 4.00 | 105.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019609 | BPC-157 | Homopeptide | HOMO-2505-F2001 | 2025-Q2 | 99.37 | 4.32 | 97.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021077 | Tirzepatide | WXT | WXT-2411-F4668 | 2025-Q2 | 97.64 | 4.90 | 100.5 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020789 | Semaglutide | SGN | SGN-2502-J9961 | 2025-Q2 | 97.90 | 4.65 | 100.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018551 | TB-500 | WWB | WWB-2501-Y4287 | 2025-Q2 | 99.57 | 3.29 | 90.5 | Laboratory-retained | 3 | MARGINAL |
| AX-2025-021192 | PT-141 (Bremelanotide) | BCH | BCH-2502-H6657 | 2025-Q2 | 99.61 | 5.46 | 92.1 | Supplier-supplied | 0 | PASS |
| AX-2025-020621 | L-Carnosine | SSA | SSA-2504-T7815 | 2025-Q2 | 99.30 | 7.19 | 93.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019538 | Semaglutide | Homopeptide | HOMO-2501-A1307 | 2025-Q2 | 99.61 | 6.23 | 90.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019061 | Liraglutide | JEEP | JEEP-2411-B3841 | 2025-Q2 | 99.92 | 5.11 | 104.5 | Supplier-supplied | 0 | PASS |
| AX-2025-018983 | SS-31 (Elamipretide) | FGP | FGP-2501-F1566 | 2025-Q2 | 99.93 | 5.10 | 91.6 | Supplier-supplied | 0 | PASS |
| AX-2025-018783 | TB-500 | QSC | QSC-2504-T7980 | 2025-Q2 | 99.93 | 3.77 | 105.6 | Supplier-supplied | 0 | PASS |
| AX-2025-018738 | Semaglutide | QSC | QSC-2412-F7396 | 2025-Q2 | 99.29 | 3.36 | 103.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021221 | Tirzepatide | BCH | BCH-2501-D6269 | 2025-Q2 | 96.65 | 4.81 | 99.5 | Supplier-supplied | 1 | FAIL |
| AX-2025-019975 | BPC-157 | SWB | SWB-2504-M6687 | 2025-Q2 | 99.16 | 4.31 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019354 | N-Acetyl Semax Amide | TFC | TFC-2411-F7283 | 2025-Q2 | 98.45 | 10.99 | 96.7 | Supplier-supplied | 0 | FAIL |
| AX-2025-018906 | GHRP-6 | FGP | FGP-2411-J1249 | 2025-Q2 | 99.93 | 5.70 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019449 | Tirzepatide | Homopeptide | HOMO-2502-U9233 | 2025-Q2 | 98.63 | 5.60 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019082 | Tirzepatide | JEEP | JEEP-2412-U3223 | 2025-Q2 | 99.00 | 2.56 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018896 | MK-677 (Ibutamoren mesylate) | FGP | FGP-2502-F9841 | 2025-Q2 | 98.93 | 4.67 | 100.5 | Supplier-supplied | 1 | FAIL |
| AX-2025-018649 | N-Acetyl Semax Amide | QYB | QYB-2411-G5768 | 2025-Q2 | 99.93 | 9.62 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020131 | Ipamorelin | GGPeps | GGPE-2411-B9190 | 2025-Q2 | 98.60 | 5.42 | 103.7 | Buyer-sourced | 1 | FAIL |
| AX-2025-019764 | Semaglutide | HJ | HJ-2504-Y4203 | 2025-Q2 | 99.45 | 4.68 | — | Supplier-supplied | 0 | PASS |